E-MYCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover E-mycin, and when can generic versions of E-mycin launch?
E-mycin is a drug marketed by Arbor Pharms Inc and Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in E-MYCIN is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E-mycin
A generic version of E-MYCIN was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
Summary for E-MYCIN
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 103 |
Patent Applications: | 4,696 |
Formulation / Manufacturing: | see details |
DailyMed Link: | E-MYCIN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for E-MYCIN
US Patents and Regulatory Information for E-MYCIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Inc | E-MYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 060272-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | E-MYCIN E | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062198-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Arbor Pharms Inc | E-MYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 060272-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pharmacia And Upjohn | E-MYCIN E | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062198-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |